MSL Leaders



	Search:




Essential MS Insights: Web Conferences based on the proceedings from the recent Multisite Think Tank on the Challenges of Multiple Sclerosis


Multiple sclerosis (MS) is treated in a variety of clinical practice settings ranging from tertiary MS centers that specialize in managing MS patients to community-based neurologist’s offices. In the absence of clinical guidelines and with identified, critical gaps in available data, the approach to the management of the MS patient also varies widely, particularly amongst community-based neurologists.

			Benjamin Greenberg, MD, MHS (Program chair) Assistant Professor Johns Hopkins School of Medicine Department of Neurology Co-Director Johns Hopkins Transverse Myelitis Center




	How do you manage patients that report paralyzing symptoms in one or both legs post injection of interferon (beta-1a)? Should these patients continue therapy or are there any medications that can be given to prevent or manage this reaction?


	Two different post-interferon injection syndromes seem to account for most of these events: First, even relatively small increases in core body temperature post-injection can result in temporary, but reversible leg muscle weakness. The pathophysiology of this seems to be closely related to the well-known Uhthoff's phenomenon.




	Changing Therapy in Relapsing MS

	Diagnosis and Management of Primary Progressive Multiple Sclerosis

	MS Highlights of the American Academy of Neurology 2007 Annual Meeting

	Recent Clinical Trials: CHAMPIONS and BENEFIT Investigators Discuss Their Studies

	PML: What MS-Treating Clinicians Need To Know (12/07)

	Treatment of Spasticity in Patients With Multiple Sclerosis (8/07)

	MS Highlights of the Annual Meeting of the American Academy of Neurology April 2006

	Treatment of Acute Multiple Sclerosis Relapses (1/07)

	Management of the Breakthrough Patient (1/06)

	Controversies in The Early Treatment of MS: A Pro & Con Debate (12/06)

	Using Motivational Interviewing Techniques in the Care of the Multiple Sclerosis Patient (9/05)

	Multidisciplinary Approach to Care of the MS Patient (8/05)

	A Patient-Centered Approach to the Treatment of MS (5/05)

	Update on Neutralizing Antibodies in MS Treatment (7/05)



	Management of Side Effects the Treatment of Multiple Sclerosis (9/04)

	Multiple Sclerosis, Depression and Suicide (03/03)

	Symptom Management in Multiple Sclerosis: Spasticity, and Bladde and Sexual Dysfunction (4/04)

	The Management of Fatigue and Cognitive Dysfunction Associated with Multiple Sclerosis (2/04)

Multidisciplinary Approach to Care of the MS Patient

One of the most distressing symptoms of multiple sclerosis (MS) can be the phenomenon of spasticity. Advances have been made in its treatment and control in recent years but many clinicians who treat MS may not be familiar with the intricacies of technologies, such as intrathecal baclofen and botulinum toxin. Additionally, a team approach to care can greatly enhance the care of patients with spasticity. Many disciplines play a role in its management, attendant ambulatory disability, and motor dysfunction.

Peggy Crawford, PhD
Gloria J. Morin, OTR/L
Marie Namey, RN, MSN, MSCN
Patricia Provance, PT, MSCS
Katherine Treadaway, LCSW


Using Motivational Interviewing Techniques in the Care of the Multiple Sclerosis Patient

There is evidence that patient-centered approaches to health care consultations may have better outcomes than traditional advice giving, especially when lifestyle change is involved. Motivational interviewing (MI) is a patient-centered approach that is gathering increased interest in health settings. It provides a way of working with patients who may not seem ready to make the behavior changes that are considered necessary by the health practitioner.

Ken Resnicow, PhD (Moderator)
Deanna Broujos
Celeste Egan
April M. Hopper, PharmD
Faith Reilly, RN


	Search: